Neogen Co. (NASDAQ:NEOG) Director James L. Herbert sold 5,000 shares of the company’s stock in a transaction on Monday, July 15th. The shares were sold at an average price of $62.93, for a total value of $314,650.00. Following the completion of the transaction, the director now directly owns 626,484 shares in the company, valued at $39,424,638.12. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.
Shares of NEOG opened at $63.97 on Friday. The stock’s 50-day moving average is $60.75. The firm has a market cap of $3.37 billion, a P/E ratio of 52.87, a P/E/G ratio of 5.32 and a beta of 1.34. Neogen Co. has a fifty-two week low of $50.60 and a fifty-two week high of $97.38.
A number of institutional investors and hedge funds have recently made changes to their positions in NEOG. Manchester Capital Management LLC boosted its stake in shares of Neogen by 105.6% during the 1st quarter. Manchester Capital Management LLC now owns 590 shares of the company’s stock worth $34,000 after acquiring an additional 303 shares in the last quarter. Brand Asset Management Group Inc. purchased a new stake in shares of Neogen during the 1st quarter worth about $39,000. Ellis Investment Partners LLC purchased a new stake in shares of Neogen during the 1st quarter worth about $40,000. Buffington Mohr McNeal purchased a new stake in shares of Neogen during the 1st quarter worth about $43,000. Finally, Captrust Financial Advisors boosted its stake in shares of Neogen by 47.0% during the 4th quarter. Captrust Financial Advisors now owns 970 shares of the company’s stock worth $55,000 after acquiring an additional 310 shares in the last quarter. 90.09% of the stock is currently owned by institutional investors.
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.
Further Reading: Google Finance Portfolio
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.